Breaking News

You are here » Indian-Commodity  :  Commodities  :  Wheat  :  Wheat futures trade down on poor demand

20-Jun2013

Wheat futures trade down on poor demand

Wheat futures trade down on NCDEX due to poor wheat procurement by government in the current year. Moreover, poor demand by flour millers in the local mandies also pressurized the wheat prices in the domestic market.

The contract for June delivery was trading at Rs 1585.00, down by 0.06% or Rs 1.00 from its previous closing of Rs 1586.00. The open interest of the contract stood at 1100.00 lots.


Related News

View all news

Government raises custom duty on wheat to 30%

In order to protect domestic growers from cheap imports, the government has raised the customs duty on wheat to 30% from 20% earlier. The increase in import duty on wheat comes in the wake of record domestic......

Wheat procurement up 16% to 31.87 MT so far

The procurement of wheat has risen by 16% and stood at 31.87 million tonnes (MT) so far in this marketing year and is all set to cross the government's target of 32 MT. As many as 18,326 centres have been......

Government procures 19.31 LT of wheat in current marketing year

The government has procured 19.31 lakh tonnes (LT) of wheat from farmers in the current marketing year so far. The government has fixed wheat procurement target at 320 LT for 2018-19 marketing year, as......

Top News

View all news

Aurobindo Pharma, TVS Motor and Lupin to see some action today

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc., has entered into an agreement to acquire a product under development and related assets from 'Advent Pharmaceuticals Pty, Australia,......

TVS Motor launches TVS Apache RTR 160 4V in Bangladesh

TVS Motor Company has launched the TVS Apache RTR 160 4V in Bangladesh. A testimony to the racing legacy of the TVS Apache RTR series, the TVS Apache RTR 160 4V will be the flagship offering of the brand......

Aurobindo Pharma's arm enters into agreement with Advent Pharma

Aurobindo Pharma's wholly owned subsidiary -- Aurobindo Pharma USA Inc. -- has entered into an agreement to acquire a product under development and related assets from Advent Pharmaceuticals Pty, Australia,......